Dr. Reddy’s Labs (RDY) Sinks Lower Following FDA Warning Letter

Dr. Reddy’s Labs (RDY) Sinks Lower Following FDA Warning Letter

Dr. Reddy’s Laboratories, an India-based manufacturer and exporter of bulk generics, has been issued a Warning Letter by the FDA in November, 2015. The FDA says this warning was because it discovered a quality control lab in the company that it had not known earlier. This caused Dr. Reddy’s shares to plunge by about 4 percent in the trading market.

For more information : http://www.compliance4all.com/



Author: compliance4all

Compliance4All, the ultimate continuing professional education provider offers you regulatory and compliance trainings from the industry's leading experts, but with one crucial difference -the cost. Compliance4All's objective is to be a platform that provides regulatory and compliance trainings with all the class and features that come with these trainings, at a lower price. Compliance4All seeks to make regulatory and compliance trainings low-hanging fruits. Industries We Focus On: • Trade & Logistics • Aerospace Defense • Banking & Insurance • Food & Beverages • Auditing/Accounting & Tax • Energy • Environment • Education • Automotive Transport • Science and Technology • Government • Construction • Electronics & Semiconductor • Operation • Engineering/Science • Purchasing & Vendor Relation • General counsel/Accountant • Geology & Mining • Documentation/Records

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s